检索结果 - Markus Kohlmann
- Showing 1 - 3 results of 3
-
1
First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of <scp>TNFR1</scp> Signaling in Healthy Participants 由 Nassr Nassr, Faı̈za Rharbaoui, Dietmar Weitz, Johann Gassenhuber, Markus Rehberg, Markus Kohlmann, F. Schumacher, Amel Lahmar, Andreas Kovar, Laurent Perrin, Frank‐Dietrich Wagner, Maria Wiekowski, Mai Anh Nguyen
出版 2025Artigo -
2
Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor 由 Matthias Löhn, Oliver Plettenburg, Yuri Ivashchenko, Aimo Kannt, Armin Hofmeister, Dieter Kadereit, Matthias Schaefer, Wolfgang Linz, Markus Kohlmann, Jean‐Marc Herbert, Philip Janiak, Stephen E. O'Connor, Hartmut Ruetten
出版 2009Artigo -
3
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis 由 Alexander Vugler, James P. O’Connell, Mai Ánh Nguyễn, Dietmar Weitz, Thomas Leeuw, Elizabeth S Hickford, Alexander Verbitsky, Xiaoyou Ying, Markus Rehberg, Bruce Carrington, Mark Merriman, Andrew Moss, Jean-Marie Nicholas, Phil Stanley, S. Kirk Wright, Tim Bourne, Yann Foricher, Zhaoning Zhu, Daniel C. Brookings, Helen Horsley, Jag Heer, Laurent Schio, Matthias Herrmann, Srinivas Rao, Markus Kohlmann, Peter Florian
出版 2022Artigo
相关主题
Pharmacology
Internal medicine
Medicine
Tumor necrosis factor alpha
Adverse effect
Antibody
Arthritis
Autoimmune disease
Biology
Cell biology
Chemistry
Cytokine
Dosing
Endocrinology
Fasudil
Focal adhesion
Immunology
Inflammation
Kinase
Mediator
Myosin
Myosin light-chain kinase
Myosin-light-chain phosphatase
Oral administration
Pharmacodynamics
Pharmacokinetics
Proinflammatory cytokine
Protein kinase A
RHOA
Receptor